OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells $103,000.00 in Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Squadron Capital Llc sold 4,000 shares of the firm’s stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $25.75, for a total transaction of $103,000.00. Following the sale, the insider owned 6,897,764 shares of the company’s stock, valued at approximately $177,617,423. This represents a 0.06% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Squadron Capital Llc also recently made the following trade(s):

• On Wednesday, August 26th, Squadron Capital Llc sold 18,000 shares of OrthoPediatrics stock. The shares were sold at an average price of $24.28, for a total transaction of $437,040.00.
• On Tuesday, August 25th, Squadron Capital Llc sold 16,300 shares of OrthoPediatrics stock. The stock was sold at an average price of $24.74, for a total value of $403,262.00.

OrthoPediatrics Stock Performance

Shares of OrthoPediatrics stock traded down $0.47 on Wednesday, hitting $24.03. The stock had a trading volume of 169,608 shares, compared to its average volume of 171,545. The stock has a market cap of $627.42 million, a price-to-earnings ratio of -14.30 and a beta of 0.98. The company has a quick ratio of 2.17, a current ratio of 4.78 and a debt-to-equity ratio of 0.28. OrthoPediatrics Corp. has a twelve month low of $14.42 and a twelve month high of $26.74. The business’s 50 day moving average is $21.11 and its two-hundred day moving average is $18.53.

OrthoPediatrics (NASDAQ:KIDS) last posted its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) earnings per share for the quarter, topping the consensus estimate of ($0.30) by $0.04. The firm had revenue of $70.51 million for the quarter, compared to analysts’ expectations of $68.21 million. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%. Analysts forecast that OrthoPediatrics Corp. will post -1.14 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. Piper Sandler reiterated an “overweight” rating and set a $25.00 target price (up from $22.00) on shares of OrthoPediatrics in a research report on Wednesday, August 5th. Truist Financial set a $22.00 price target on OrthoPediatrics in a research note on Wednesday, August 5th. Weiss Ratings upgraded shares of OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 5th. BTIG Research raised their target price on shares of OrthoPediatrics from $24.00 to $29.00 and gave the company a “buy” rating in a report on Thursday, August 20th. Finally, TD Cowen reiterated a “buy” rating on shares of OrthoPediatrics in a research report on Monday, June 15th. Nine investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $26.44.

Institutional Trading of OrthoPediatrics

Large investors have recently bought and sold shares of the business. California State Teachers Retirement System raised its stake in OrthoPediatrics by 397.1% during the second quarter. California State Teachers Retirement System now owns 4,553 shares of the company’s stock worth $87,000 after acquiring an additional 3,637 shares in the last quarter. Nantahala Capital Management LLC bought a new stake in shares of OrthoPediatrics during the 2nd quarter valued at approximately $4,636,002,000. Grandeur Peak Global Advisors LLC bought a new stake in shares of OrthoPediatrics during the 2nd quarter valued at approximately $954,000. Bank of America Corp DE acquired a new position in OrthoPediatrics during the 2nd quarter worth approximately $268,000. Finally, AWM Investment Company Inc. acquired a new position in OrthoPediatrics during the 2nd quarter worth approximately $4,537,000. 69.05% of the stock is owned by institutional investors and hedge funds.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.